Sphingolipids in embryonic development, cell cycle regulation, and stemness - Implications for polyploidy in tumors

Semin Cancer Biol. 2022 Jun:81:206-219. doi: 10.1016/j.semcancer.2020.12.027. Epub 2021 Jan 8.

Abstract

The aberrant biology of polyploid giant cancer cells (PGCC) includes dysregulation of the cell cycle, induction of stress responses, and dedifferentiation, all of which are likely accompanied by adaptations in biophysical properties and metabolic activity. Sphingolipids are the second largest class of membrane lipids and play important roles in many aspects of cell biology that are potentially relevant to polyploidy. We have recently shown that the function of the sphingolipid enzyme acid ceramidase (ASAH1) is critical for the ability of PGCC to generate progeny by depolyploidization but mechanisms by which sphingolipids contribute to polyploidy and generation of offspring with stem-like properties remain elusive. This review discusses the role of sphingolipids during embryonic development, cell cycle regulation, and stem cells in an effort to highlight parallels to polyploidy.

Keywords: Cell cycle; Embryonic development; Polyploidy; Sphingolipid; Stem cells.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Cycle
  • Embryonic Development
  • Humans
  • Neoplasms* / genetics
  • Polyploidy
  • Sphingolipids* / metabolism

Substances

  • Sphingolipids